U.S. Markets closed

Incyte Corporation (INCY)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
124.34-2.03 (-1.61%)
At close: 4:00PM EDT

124.34 0.00 (0.00%)
After hours: 4:15PM EDT

People also watch
VRTXBMRNALXNREGNSGEN
  • A
    Anonymous
    Anonymous
    BMS has reported topline from a study of Opdivo + Yervoy (immunotherapy + checkpoint drug) against kidney cancer. In general, the combination was directionally better than BAT, but didn't reach statistical significance on the key progression-free survival endpoint (DID reach signicance on overall response rate). Overall survival looked good, but can't be interpreted yet. The study will continue; the combination will probably be used, but probably won't go on-label.

    This continues the pattern of immunotherapy + active agent giving unspectacular results. That is GOOD for peddlers of immunotherapy + booster combinations (ie, Incyte) where the results have sometimes been spectacular.

    However, this seems to be getting interpreted as a double-whammy (anyone else remember Evil-Eye Fleegle?) against Incyte--on the one hand, an IO drug combination disappointed / on the other hand, the combination is still probably an improvement and will raise the bar for epac. Do note that Yervoy has a substantial rate of serious AEs both on its own and in combinations. Epac's AEs are not generally regarded as serious.
  • D
    DQSjr
    DQSjr

    Read the article for yourself as Tommy will only post to satisfy his own personal narrative!

    https://finance.yahoo.com/m/7073c7dc-fc6b-3075-8dbd-f9d84ffe0986/why-gilead-sciences-might-not.html

    Why Gilead Sciences Might Not Make an Oncology Acquisition
    Gilead Sciences' CEO hints that buying a biotech with an oncology focus might not happen. Here's what this could mean for the big biotech.
    finance.yahoo.com
  • M
    Michael-P
    Michael-P
    INCY shares on sale again... Put on your seat belt. When the buyout comes one of these Mondays, that's when the longs are rewarded. My gut feeling is Gilead is indeed processing an offer and the CEO is doing whatever he can to squash speculation. i would think that this maybe brings the deal under 200 ppp (with bad luck bari delay), but Gilead would try to sell bari rights back to Lilly anyway, at least that's what one analyst had suggested. Hold on longs! Stay in your bunker. We appear to be experiencing BMS fallout. It is collateral damage, not INCY. First Korea, now this... kind of a double whammy. Will recover soon.
  • D
    DQSjr
    DQSjr
    Still in our range and some interesting activity taking place Level II showing buying taking place on the drops.
    Have to believe until GILD makes/announces a purchase...INCY still a top contender and we ride that possibility. We might find someone else comes out and beats GILD to the punch. Until such time...watch the moves associated with "volume" and what is moving the price. Ignore Tommy...he only comes out on Red Days with nothing but agenda driven commentary.
  • T
    Tom
    Tom
    MF gild make fore go an oncology purchase
  • B
    B
    B
    Heading to $100.... drip, drip!
  • D
    DQSjr
    DQSjr
    Funny how CNBC is fighting for viewers by pushing the N. Korea narrative - republishing Trump's tweets from this morning and saying how new it was - and Eamon Javers face shows up when the market starts to move up. They need/want volatile markets so people watch them more than markets going up with no volatility. So self-serving.
  • A
    Anonymous
    Anonymous
    Well, even though INCY has only moved WITHIN its trading range, it looks like SOMETHING has happened. Fear of a war with DPRK has chased a lot of money out of "hot money"-type funds. And Incyte is over-represented in those funds because it has been, well, hot. This is being and will probably continue to be offset (more slowly) by increased ownership in the medium-sized trust accounts that appear to be the largest part of non-core Incyte ownership. So while Thursday's bloodbath is likely to be substantially retraced, it could happen again, given the same sort of reason. Best case for a war in Korea is reminiscent of Iraq, worst plausible case is probably something like Falklands. And if things cool off this time, they could come back with just as little notice.

    The thing I'd like to warn my friends about, though, is the likelihood of low-level cyberattacks. "WannaCry," the ransomware that set off the recent awareness of that sort of threat, appears to have been a personal project of haxx0rzz available to the North Korean government. And NotPetya, generally CALLED ransomware in news stories, is actually a cyberweapon. In a showdown that was carefully being kept short of nuclear, a lot of malware attacks against "soft targets" [us] would be likely. Frequent back-ups to repositories that are NOT network-accessible would be A Real Good Idea for the next few weeks. And this isn't a time I'd favor getting an expensive new computer--hardware-destroying malware may circulate.
  • D
    DQSjr
    DQSjr
    Can finally buy the dips in this market!! Thanks N. Korea and Trump!!
  • D
    DQSjr
    DQSjr
    Analyst's comments about GILD: "The challenge seems to be less about simply cost and rather a question of conviction in prospective targets paying off down the line- and whether these companies are game to sell at a price CEO John Mulligan can accept. For now, the GILD CEO does not see "much sense" in buying "something small" just to buy. Rather, the indication appears to be pointing to an objective of acquiring a company that in its present stage of the game already has compelling value "to meet their hurdle for transformative potential.""
  • T
    Tom
    Tom
    INCYTE down nearly $5.00 for the week, longs keep spewing BS on how great this stock is, oh and gild will buy them out

    HAHAHAHAHAHAHAHA
  • m
    madeoff
    madeoff
    Donald & I Just finished working on new tweeter material, stay tuned.
    Maddi & Longs are loosin it big time.
    Maddi & 3 stooges approach to pickin & grinning on stocks
    Always fallin flat on their face, ba ha ha
    Imagefreyks
  • B
    B
    B
    Drip, drip..,, one step forward, two steps back...
    Imagethevortexofourminds
  • A
    Anonymous
    Anonymous
    So far, this is a movement within my estimated trading range ($122-132). To the extent that the downtick in inflation is causing today's negativity, it is less threatening to pharma than to other sectors--but that sort of differentiation doesn't happen right away. Famously, war [and rumors of war] is a temporary influence on stock prices [Matthew, 24:6 is surprisingly apposite:
    "And ye shall hear of wars and rumours of wars: see that ye be not troubled: for all these things must come to pass, but the end is not yet.".

    I've been watching bank failures as an early warning of deflation. While the declining trend of recent years has reversed, there hasn't been a new one since mid-May.
  • T
    Tom
    Tom
    disappointed it did not take out 200dma, off by .8 still waiting for 140maddi
  • T
    Tom
    Tom
    still waiting for 140, seems the price keeps going down
  • w
    wereinayelllowsubmarine
    wereinayelllowsubmarine
    Are you still buying into the analysts' shiny price targets? If all you had to do was buy what the analysts recommended, wouldn't everyone be a billionaire? Wouldn't the analysts be trillionaires? Food for thought.

    Do you know any billionaire analysts? Do you know any 9-figure millionaire analysts? Have you even heard of such a thing as a 8-figure analyst? If the analysts knew how to pick stocks, they wouldn't be called analysts anymore... they'd be called investors. Please don't be insulted because it's my post, just really think about why "analysts" are paid a salary.

    Find me an analyst whose recommendations are correct 2/3 of the time, that analyst should earn at least 8-figures.

    Find me an analyst who's right more than 1/2 the time, they should earn 7-figures.

    You might find an analyst who's correct 1/2 the time, but even that is extremely rare. Almost all analysts are correct less than 1/2 of the time. I hope you didn't gamble your money on the recommendations of these analysts.
  • T
    Tom
    Tom
    margin calls coming round to the pumping longs
  • T
    Tom
    Tom
    volume picking up, large push into the abyss
  • M
    Maddison
    Maddison
    Every dog has his day... Tommy sets record with 46 posts in 5 hours... question for MB... Why would a sane person post 46 times in 5 hours... Please B...I don't need any pictures or videos... The whole market tanked today...yes INCY went down more of a percentage than IBB... What is wrong with someone that thinks posting 46 times in 5 hours is "normal behavior"...